Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
MindImmune Therapeutics is a pharmaceutical company developing drugs to treat diseases of the central nervous system.
Enodia Therapeutics is a biotech company that provides transforming treatments for cancer, inflammation, and viral infection diseases.
Syneron is a company that using artificial intelligence and biotechnology to address two significant global challenges.
4D Molecular Therapeutics designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.
Crossbow Therapeutics is a biotech company developing a new type of cancer treatment.
OTR Therapeutics is a biotechnology company developing platform-based treatments using modular RNA and delivery systems.
TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.
EvolveImmune is pioneering a pipeline of unique trispecific T cell engagers with integrated CD2 costimulation.
Ervaxx is illuminating the immune interface to develop new cancer therapies.
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Curve develops an innovative screening platform.
Targeting pathways that modify RNA to deliver novel cancer therapeutics
Nucleome Therapeutics is decoding the dark matter of the human genome to uncover novel ways to treat diseases
Anaveon is a developing IL-2 complexes which selectively promote effector T cell functions.
Kestrel Therapeutics is a medical research and devenlopment company that offers treatment solutions for RAS cancers.
Anjarium is focused on creating new class of non-viral gene therapies to deliver predictable ,inclusionary ways to tackle genetic diseases.
Montis Biosciences is develops novel immune-oncology therapeutics targeting the intersection between vascular dysfunction.
Palleon Pharmaceuticals is a developer of a biotechnology platform designed to offer glycoimmune checkpoint inhibitors to treat cancer.
Metabomed designs drugs that treats cancer.
Triplet is developing transformative therapies that treat repeat expansion disorders at their source.
Mitokinin is operates in the healthcare industry focusing on biotechnology business.
NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing
Cydan is an orphan drug accelerator focused on identifying and de-risking compounds with therapeutic and commercial potential.
Autifony Therapeutics is a biotechnology company developing medicines to treat hearing disorders such as hearing loss and tinnitus.
Pfizer Venture Investments has invested in 52 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Pfizer Venture Investments's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Pharmaceutical. The firm invests across 14 different industry categories.
Among tracked funding rounds, Anaveon received $119.7M in a Series B round. Pfizer Venture Investments's total known invested capital is $2.1B.
Pfizer Venture Investments's average investment size is $50.3M across its portfolio of 52 companies.
Recent Pfizer Venture Investments portfolio additions include MindImmune Therapeutics, Enodia Therapeutics, Syneron, 4D Molecular Therapeutics, Crossbow Therapeutics. These companies were founded in 2020 or later.